When you tilt your head back and squeeze a drop of solution into your eye, you expect absolute purity. Because the eye is one of the most sensitive and vulnerable organs in the human body, even the slightest impurity can feel like a major injury. Consumers take it for granted that their ophthalmic drops are perfectly clear and safe. But for pharmaceutical manufacturers, achieving that absolute clarity means looking far beyond what the human eye can see.
What remains invisible to the naked eye poses the greatest regulatory and physiological risk. That is why ophthalmic solution testing is subjected to some of the strictest standards in the pharmaceutical industry. Chief among these is USP 789, the regulatory chapter dedicated exclusively to monitoring particulate matter in eye care products.
Understanding how we hunt down these microscopic anomalies requires a balance of advanced automation, human artistry, and a deep appreciation for patient safety.
Why Subvisible Particles Cause Visible Harm
Under ideal conditions, human vision can only spot particles that are 50 microns (μm) or larger. To put that in perspective, a single strand of human hair is about 70 μm wide. USP 789 strictly regulates subvisible particle testing down to 10 μm and 25 μm.
If a microscopic piece of glass, plastic, rubber, or environmental dust finds its way into an eye drop, it doesn’t just sit there. When applied directly to the cornea, these tiny particles act like micro-abrasives. Every blink causes the eyelid to drag that subvisible particle across the delicate surface of the eye, which could lead to:
- Foreign-body sensation and persistent irritation
- Corneal scratching or micro-tears
- Localized inflammation or secondary infections
For a patient already using a medicated eye drop to treat an injury, glaucoma, or post-surgical recovery, the presence of particulate matter pharmaceutical contaminants can actively sabotage their healing.
The Two Frontlines of Defense: Method I and Method II
To ensure patient safety, USP 789 outlines a meticulous, two-stage testing framework. At Particle Technology Labs, we utilize both pathways to give manufacturers definitive, audit-ready clarity.
Method I: Light Obscuration (The Automated Shield)
The frontline defense in particle counting relies on advanced physics. Light obscuration is an automated technique where a liquid sample is precisely drawn through a specialized sensor containing a laser beam. As individual particles pass through the beam, they block—or obscure—a portion of the light. The instrument calculates the exact size and number of particles based on how much light is lost.
The AccuSizer® A7000 SIS used at PTL
To perform this with maximum precision, our team utilizes the industry-leading Entegris AccuSizer® A7000 SIS system. Unlike standard monitoring systems that group particles into broad categories, the AccuSizer utilizes single particle optical sensing (SPOS) paired with over 512 distinct sizing channels. This allows us to map out an incredibly detailed sizing distribution profile.Under the strict rules of USP 789, an ophthalmic solution passes this stage only if the average count does not exceed these stringent limits:
- ≥ 10 µm: No more than 50 particles per mL
- ≥ 25 µm: No more than 5 particles per mL
- ≥ 50 µm: No more than 2 particles per mL
Method II: Manual Microscopy (The Trained Eye)
What happens if a complex formulation—like an emulsion or a suspension drop—disrupts the light path of an automated counter? Or what if a sample fails Method I?
That is when the standard demands a secondary, human intervention. Method II requires manual microscopy.
During this stage, a highly trained PTL chemist filters the liquid sample through a fine membrane grid to trap the particles physically. The chemist then sits at a specialized benchtop microscope—specifically the high-caliber Nikon Eclipse Ci POL—and visually scans the grid.
The Nikon Eclipse Ci POL used at PTL
This process requires remarkable skill. The chemist must carefully count and measure every single foreign particle caught on the filter, validating the automated results and providing critical context about the shape and nature of the contaminant.
Moving Forward with Confidence
Ophthalmic manufacturers must eliminate all guesswork, regardless of whether they are producing a basic over-the-counter artificial tear or a highly specialized prescription therapeutic.
Our lab is equipped to handle both stages of the compliance process exactly as the standard intends. For most projects, the rapid, high-resolution automated power of the AccuSizer A7000 SIS is all that’s required to clear your product. But if your formulation is complex or a Stage 1 limit is exceeded, our team can seamlessly pivot to manual microscopy using the Nikon Eclipse Ci POL to provide the necessary verification.
Are you an ophthalmic solution manufacturer preparing for a product launch or evaluating supply chain quality? Our expert team is here to handle the analytical heavy lifting. Reach out to Particle Technology Labs today to schedule your compliance testing and move forward with absolute confidence.
